Open AccessDaratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)
Author(s) -
Rathi N. Pillai,
Suresh S. Ramalingam,
Meena Thayu,
Patricia Lorenzini,
Diana Alvarez Arias,
Christopher Moy,
Natalie A. Hutnick,
R.E. Knoblauch,
Huaibao Feng,
Colleen Kane,
Leora Horn,
Martin Reck,
Santiago Ponce
Publication year - 2020
Publication title -
jto clinical and research reports
Language(s) - English
Resource type - Journals
ISSN - 2666-3643
DOI - 10.1016/j.jtocrr.2020.100104
Subject(s) - atezolizumab , medicine , oncology , daratumumab , phases of clinical research , clinical trial , immunotherapy , cancer , nivolumab , multiple myeloma , lenalidomide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom